Loading…
SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.
Also known as: AGIOS PHARMACEUTICALS, AGIOS PHARMACEUTICALS
Client-Reported Lobbying Expenses
$180K
7 filings
Summary
AGIOS PHARMACEUTICALS is an organization, based in MA. Its political footprint includes $180K in client-reported lobbying expenses. Lobbying activity focuses on Health Issues, Medicare/Medicaid, Medical/Disease Research/Clinical Labs, Pharmacy. Political activity spans from 2025 to 2026.
These are different money flows and are not added together: contributions and lobbying expenses flow out, while contract awards flow to the organization.
Lobbying Spend Trend
↑ 160% YoY
2026: $130K (available years)
Activity data: Senate LDA